• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

家族性相关突变以不同方式破坏帕金森蛋白的溶解性、定位、结合和泛素化特性。

Familial-associated mutations differentially disrupt the solubility, localization, binding and ubiquitination properties of parkin.

作者信息

Sriram Sathya R, Li Xiaojie, Ko Han Seok, Chung Kenny K K, Wong Esther, Lim Kah Leong, Dawson Valina L, Dawson Ted M

机构信息

Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.

出版信息

Hum Mol Genet. 2005 Sep 1;14(17):2571-86. doi: 10.1093/hmg/ddi292. Epub 2005 Jul 27.

DOI:10.1093/hmg/ddi292
PMID:16049031
Abstract

Mutations in parkin are largely associated with autosomal recessive juvenile parkinsonism. The underlying mechanism of pathogenesis in parkin-associated Parkinson's disease (PD) is thought to be due to the loss of parkin's E3 ubiquitin ligase activity. A subset of missense and nonsense point mutations in parkin that span the entire gene and represent the numerous inheritance patterns that are associated with parkin-linked PD were investigated for their E3 ligase activity, localization and their ability to bind, ubiquitinate and effect the degradation of two substrates, synphilin-1 and aminoacyl-tRNA synthetase complex cofactor, p38. Parkin mutants vary in their intracellular localization, binding to substrates and enzymatic activity, yet they are ultimately deficient in their ability to degrade substrate. These results suggest that not all parkin mutations result in loss of parkin's E3 ligase activity, but they all appear to manifest as loss-of-function mutants due to defects in solubility, aggregation, enzymatic activity or targeting proteins to the proteasome for degradation.

摘要

帕金森蛋白(parkin)的突变主要与常染色体隐性少年帕金森病相关。帕金森蛋白相关帕金森病(PD)发病的潜在机制被认为是由于帕金森蛋白E3泛素连接酶活性丧失。研究了帕金森蛋白中一系列错义及无义点突变,这些突变贯穿整个基因,代表了与帕金森蛋白相关帕金森病相关的多种遗传模式,检测了它们的E3连接酶活性、定位以及结合、泛素化和影响两个底物(突触核蛋白-1和氨酰-tRNA合成酶复合物辅因子p38)降解的能力。帕金森蛋白突变体在细胞内定位、与底物的结合及酶活性方面存在差异,但它们最终在降解底物的能力上存在缺陷。这些结果表明,并非所有帕金森蛋白突变都会导致其E3连接酶活性丧失,但由于溶解性、聚集、酶活性或靶向蛋白至蛋白酶体进行降解方面的缺陷,它们似乎都表现为功能丧失突变体。

相似文献

1
Familial-associated mutations differentially disrupt the solubility, localization, binding and ubiquitination properties of parkin.家族性相关突变以不同方式破坏帕金森蛋白的溶解性、定位、结合和泛素化特性。
Hum Mol Genet. 2005 Sep 1;14(17):2571-86. doi: 10.1093/hmg/ddi292. Epub 2005 Jul 27.
2
Biochemical analysis of Parkinson's disease-causing variants of Parkin, an E3 ubiquitin-protein ligase with monoubiquitylation capacity.帕金森病相关的Parkin变异体的生化分析,Parkin是一种具有单泛素化能力的E3泛素蛋白连接酶。
Hum Mol Genet. 2006 Jul 1;15(13):2059-75. doi: 10.1093/hmg/ddl131. Epub 2006 May 19.
3
Alterations in the solubility and intracellular localization of parkin by several familial Parkinson's disease-linked point mutations.几种与家族性帕金森病相关的点突变导致帕金蛋白的溶解度和细胞内定位改变。
J Neurochem. 2005 Apr;93(2):422-31. doi: 10.1111/j.1471-4159.2005.03023.x.
4
Covalent ISG15 conjugation positively regulates the ubiquitin E3 ligase activity of parkin.共价ISG15缀合正向调节帕金蛋白的泛素E3连接酶活性。
Open Biol. 2016 Aug;6(8). doi: 10.1098/rsob.160193.
5
Ubiquitination of a new form of alpha-synuclein by parkin from human brain: implications for Parkinson's disease.人脑中帕金蛋白对一种新型α-突触核蛋白的泛素化作用:对帕金森病的影响。
Science. 2001 Jul 13;293(5528):263-9. doi: 10.1126/science.1060627. Epub 2001 Jun 28.
6
Nitrosative stress linked to sporadic Parkinson's disease: S-nitrosylation of parkin regulates its E3 ubiquitin ligase activity.与散发性帕金森病相关的亚硝化应激:帕金蛋白的S-亚硝基化调节其E3泛素连接酶活性。
Proc Natl Acad Sci U S A. 2004 Jul 20;101(29):10810-4. doi: 10.1073/pnas.0404161101. Epub 2004 Jul 13.
7
Stress-induced alterations in parkin solubility promote parkin aggregation and compromise parkin's protective function.应激诱导的帕金蛋白溶解性改变促进帕金蛋白聚集并损害其保护功能。
Hum Mol Genet. 2005 Dec 15;14(24):3885-97. doi: 10.1093/hmg/ddi413. Epub 2005 Nov 8.
8
A disease state mutation unfolds the parkin ubiquitin-like domain.疾病状态突变使帕金泛素样结构域展开。
Biochemistry. 2007 Dec 11;46(49):14162-9. doi: 10.1021/bi7016969. Epub 2007 Nov 16.
9
[Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease].帕金森病的病因与发病机制:从线粒体功能障碍到家族性帕金森病
Rinsho Shinkeigaku. 2004 Apr-May;44(4-5):241-62.
10
Impact of altered phosphorylation on loss of function of juvenile Parkinsonism-associated genetic variants of the E3 ligase parkin.改变磷酸化对 E3 连接酶 parkin 中与青少年帕金森病相关的遗传变异体丧失功能的影响。
J Biol Chem. 2018 Apr 27;293(17):6337-6348. doi: 10.1074/jbc.RA117.000605. Epub 2018 Mar 12.

引用本文的文献

1
Computational association in parkinson's disease SNPs with brain structural and functional alterations.帕金森病单核苷酸多态性与脑结构和功能改变的计算关联
Neurogenetics. 2025 Aug 9;26(1):59. doi: 10.1007/s10048-025-00843-6.
2
PNPLA7 mediates Parkin-mitochondrial recruitment in adipose tissue for mitophagy and inhibits browning.PNPLA7介导帕金蛋白在线粒体的募集进入脂肪组织以进行线粒体自噬,并抑制脂肪褐变。
Nat Commun. 2025 Jul 19;16(1):6651. doi: 10.1038/s41467-025-61904-w.
3
Formation of seeding-competent α-synuclein aggregates in parkin-deficient iPSC-derived human neurons.
在缺乏parkin的诱导多能干细胞衍生的人类神经元中形成具有种子形成能力的α-突触核蛋白聚集体。
NPJ Parkinsons Dis. 2025 Jun 21;11(1):180. doi: 10.1038/s41531-025-01038-4.
4
Structural basis for the pathogenicity of parkin catalytic domain mutants.帕金森蛋白催化结构域突变体致病性的结构基础
J Biol Chem. 2025 Jan;301(1):108051. doi: 10.1016/j.jbc.2024.108051. Epub 2024 Dec 3.
5
Redox regulation, protein S-nitrosylation, and synapse loss in Alzheimer's and related dementias.氧化还原调节、蛋白质S-亚硝基化与阿尔茨海默病及相关痴呆中的突触丧失
Neuron. 2024 Dec 4;112(23):3823-3850. doi: 10.1016/j.neuron.2024.10.013. Epub 2024 Nov 7.
6
Structural and Functional Characterization of the Most Frequent Pathogenic PRKN Substitution p.R275W.PRKN 最常见致病性替换 p.R275W 的结构与功能特征。
Cells. 2024 Sep 13;13(18):1540. doi: 10.3390/cells13181540.
7
Capturing the catalytic intermediates of parkin ubiquitination.捕获 parkin 泛素化的催化中间体。
Proc Natl Acad Sci U S A. 2024 Aug 6;121(32):e2403114121. doi: 10.1073/pnas.2403114121. Epub 2024 Jul 30.
8
PRKN-linked familial Parkinson's disease: cellular and molecular mechanisms of disease-linked variants.PRKN 相关家族性帕金森病:疾病相关变异的细胞和分子机制。
Cell Mol Life Sci. 2024 May 20;81(1):223. doi: 10.1007/s00018-024-05262-8.
9
A mutational atlas for Parkin proteostasis.Parkin 蛋白稳态的突变图谱
Nat Commun. 2024 Feb 20;15(1):1541. doi: 10.1038/s41467-024-45829-4.
10
CK2 and protein kinases of the CK1 superfamily as targets for neurodegenerative disorders.细胞周期蛋白依赖性激酶2(CK2)和CK1超家族的蛋白激酶作为神经退行性疾病的靶点。
Front Mol Biosci. 2022 Oct 6;9:916063. doi: 10.3389/fmolb.2022.916063. eCollection 2022.